Skip to content
FY'25FY'24FY'23FY'22
$3.53M+1,779%$188K-47.9%$361K+23.2%$293K+48.0%
$196K-92.2%$2.51M
-$462.78M-4,380%-$10.33M+64.4%-$29.04M-7.4%-$27.05M+15.2%
-$9.58-1,083%-$0.81+79.8%-$4.00
129.8M+145%53M+88.6%28.1M
129.8M+145%53M+88.6%28.1M
-$7.02M
$8.05M
$57.1M+715%$7.01M-15.9%$8.34M+89.0%$4.41M-53.6%
-$461.96M-4,372%-$10.33M
$85K$9K
-$102K+70.9%-$350K-11.8%-$313K
-$30K
$0
$54.88M+1,065%$4.71M-72.8%$17.33M+64.0%$10.57M
-$186K-10.7%-$168K+69.0%
-$10.44M-119%-$4.76M+72.5%-$17.31M+20.2%-$21.71M+17.8%
$96K-69.6%$316K
$4.21M-72.5%$15.3M+84.7%$8.28M-8.0%
-$67.56M-433%-$12.67M+55.0%-$28.15M-4.4%-$26.97M+18.8%
-$71.1M-453%-$12.86M+54.9%-$28.51M-4.6%-$27.27M+18.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is BioSig Technologies, Inc.'s revenue?
BioSig Technologies, Inc. (STEX) generated $40.0K in revenue over the trailing twelve months, up 122.2% year over year.
Is BioSig Technologies, Inc. profitable?
BioSig Technologies, Inc. is not currently profitable: it reported a net loss of $506.7M over the trailing twelve months, a -25825.0% net margin.
What are BioSig Technologies, Inc.'s profit margins?
Gross margin is 80.1% and operating margin is -32155.0%, with a -25825.0% net margin.
What is BioSig Technologies, Inc.'s earnings per share?
BioSig Technologies, Inc.'s diluted EPS over the trailing twelve months is $-9.71.
Where does BioSig Technologies, Inc.'s income statement data come from?
Every line is extracted from BioSig Technologies, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.